Skip to main content
Ronald Sobecks, MD, Hematology, Cleveland, OH

RonaldMSobecksMD

Hematology Cleveland, OH

Professor of Medicine, Case Western Reserve University School of Medicine

Dr. Sobecks is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Sobecks' full profile

Already have an account?

  • Office

    9500 Euclid Ave, CA60
    Cleveland, OH 44195
    Phone+1 216-445-4626
    Fax+1 216-444-9464

Summary

  • Dr. Ronald Sobecks is a Professor of Medicine and a hematologist/oncologist at the Cleveland Clinic's Taussig Cancer Center in Cleveland, OH. He received his medical degree from Case Western Reserve University School of Medicine and has been in practice 24 years. His clinical practice and research has been with blood and marrow transplantation with hematologic malignancies.

Education & Training

  • University of Chicago
    University of ChicagoFellowship, Hematology and Medical Oncology, 1996 - 1999
  • Case Western Reserve University/University Hospitals Cleveland Medical Center
    Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Internal Medicine, 1993 - 1996
  • Case Western Reserve University School of Medicine
    Case Western Reserve University School of MedicineClass of 1993

Certifications & Licensure

  • OH State Medical License
    OH State Medical License 1995 - 2026
  • FL State Medical License
    FL State Medical License 2016 - 2018
  • IL State Medical License
    IL State Medical License 1996 - 1999
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011, 2013

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Effect of Bone Marrow CD34+Cells and T-cell Subsets on Clinical Outcomes After Myeloablative Allogeneic Hematopoietic Cell Transplantation  
    Deepa Jagadeesh, Matt Kalaycio, Brian Bolwell, Betty K Hamilton, Brian Hill, Brad Pohlman, Robert Dean, Navneet S Majhail, Sagar S Patel, Rabi Hanna, Aaron T Gerds, Ro..., Nature
  • Neutropenic Fever During Peripheral Blood Progenitor Cell Mobilization Is Associated with Decreased CD34+ Cell Collection and Increased Apheresis Collection Days  
    Mat Kalaycio, Robert Dean, Jack Khouri, Brad Pohlman, Aleksandr Lazaryan, Edward Copelan, Steven Andresen, Ronald Sobecks, Hien Liu, Journal of Clinical Apheresis

Abstracts/Posters

  • Interactions between Donor Activating Killer Immunoglobulin-like Receptors (KIRs) and Somatic Mutations and Their Association with Outcomes after Allogeneic Hematopoie...
    Ronald Sobecks, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Feedback Responses of the Pyrimidine Metabolism Network Mediate Resistance to Decitabine and 5-Azacytidine
    Ronald Sobecks, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Outcomes and Factors Impacting Use of Axicabtagene Ciloleucel in Refractory and Relapsed Large B-Cell Lymphoma: An Intent-to-Treat Analysis
    Ronald Sobecks, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Join now to see all

Lectures

  • A Personalized Prediction Model for Outcomes after Allogeneic Hematopoietic Stem Cell Transplant in Patients with Myelodysplastic Syndromes: On Behalf of the CIBMTR Ch... 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Association of MHC Class I Chain-Related Gene a (MICA) Polymorphisms with Allogeneic Hematopoietic Cell Transplantation Outcomes in Acute Myeloid Leukemia 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

  • Letter to Editor Intravenous Compared to Oral Busulfan with Cyclophosphamide for Autologous Hematopoietic Cell Transplant Conditioning for Plasma Cell Myeloma
    Letter to Editor Intravenous Compared to Oral Busulfan with Cyclophosphamide for Autologous Hematopoietic Cell Transplant Conditioning for Plasma Cell MyelomaApril 24th, 2018
  • ASH 2018: Dec 1-4
    ASH 2018: Dec 1-4December 1st, 2017
  • Cleveland Clinic Cancer Doctor
    Cleveland Clinic Cancer DoctorNovember 13th, 2016

Professional Memberships